3-Nitro-4-(piperidin-1-yl)benzoic acid

Catalog No.: 
ACZAGK546
CAS No.: 
26586-26-5
Molecular Formula: 
C12H14N2O4
Molecular Weight: 
250.25
3-Nitro-4-(piperidin-1-yl)benzoic acid structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg95%$98.00InquiryInquiry
1g95%$204.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name3-Nitro-4-(piperidin-1-yl)benzoic acid
IUPAC Name3-nitro-4-(piperidin-1-yl)benzoic acid
MDL No.MFCD00157001
Molecular FormulaC12H14N2O4
Molecular Weight250.25
SMILESO=C(O)C1=CC=C(N2CCCCC2)C([N+]([O-])=O)=C1
InChI KeyYVODCTHEVCBRCV-UHFFFAOYSA-N
Synonym3-nitro-4-piperidin-1-ylbenzoic acid(SALTDATA: FREE);3-nitro-4-(1-piperidyl)benzoic acid;3-nitro-4-piperidino-benzoic acid;Benzoic acid, 3-nitro-4-(1-piperidinyl)-
CAS No.26586-26-5

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P280-P301+P312-P302+P352-P305+P351+P338

Synthetic Route by SureRoute

1. ACZAGK546 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACQIDB596 route compound structure diagram
    ACQIDB59622090-24-0In Stock
  2. Then
  3. ACZAGK546 route product structure diagram
    ACZAGK54626586-26-5
Inquiry

2. ACZAGK546 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACJTAD681 route compound structure diagram
    ACJTAD681367-80-6In Stock
  4. Then
  5. ACZAGK546 route product structure diagram
    ACZAGK54626586-26-5
Inquiry

3. ACZAGK546 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACOEWU095 route compound structure diagram
    ACOEWU09596-99-1In Stock
  4. Then
  5. ACZAGK546 route product structure diagram
    ACZAGK54626586-26-5
Inquiry

Comments (0)